Christopher P. Martin

Chris Martin is currently Sr. Vice President and Chief Financial Officer of Research Corporation Technologies, Inc. RCT is a technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. RCT focuses on technology investments with origins from universities, research institutions and independent inventors worldwide. Along with his management responsibilities, Mr. Martin directs RCT’s medical device team and portfolio of investments.

Mr. Martin has been involved with creating, funding, and managing several startup companies and ventures. He currently serves on the boards of Leto Medical, OrthAlign, ParinGenix, Varix Medical and VasoNova.

Chris Martin earned a BS in Biology from the University of Michigan, an MS in Biomedical Engineering from the University of Southern California and an MBA from The Anderson School at UCLA.